Search

Your search keyword '"Wirtz Hubert"' showing total 646 results

Search Constraints

Start Over You searched for: Author "Wirtz Hubert" Remove constraint Author: "Wirtz Hubert"
646 results on '"Wirtz Hubert"'

Search Results

1. “Metabolic fingerprints” of cachexia in lung cancer patients

3. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

6. Lymphangioleiomyomatose

13. TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations.

15. A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation

17. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

18. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

19. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

20. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

22. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

28. Adipokines in cachexia of patients with lung cancer

32. Lymphangioleiomyomatose

34. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry

35. IGFBP3 inhibits tumor growth and invasion of lung cancer cells and is associated with improved survival in lung cancer patients

37. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment

41. Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients

44. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort

45. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study

46. Mediastinalerkrankungen

47. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

48. Erkrankungen der Atmungsorgane

50. Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

Catalog

Books, media, physical & digital resources